Physiologic-pathologic correlation in Guillain-Barre syndrome in children

Neurology

Volumn 54, Issue 1, 2000, Pages 33-39

  Lu, J L ^a   Sheikh, K A ^b   Wu, H S ^a   Zhang, J ^a   Jiang, Z F ^a   Cornblath, D R ^b   McKhann, G M ^b,c   Asbury, A K ^d   Griffin, J W ^b   Ho, Tony W ^b,e  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Acute inflammatory demyelinating neuropathy.; Acute motor axonal neuropathy; Children; Electrodiagnosis; Guillain Barre syndrome; Sural nerve biopsy

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; DEMYELINATING NEUROPATHY; ELECTRODIAGNOSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOTOR NERVE CONDUCTION; MOTOR NEUROPATHY; NERVE BIOPSY; NERVE POTENTIAL; PRIORITY JOURNAL; SURAL NERVE;

EID: 18744437424     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.1.33     Document Type: Article

References (42)

1. Wu HS, Liu TC, Lu ZL, et al. A prospective clinical and electrophysiologic survey of acute flaccid paralysis in Chinese children. Neurology 1997;49:1723-1725.
2. de Quadros CA, Hersh BS, Olive JM, et al. Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988-1995. J Infect Dis 1997;175(suppl 1):S37-S42.
3. Haymaker W, Kernohan JW. The Landry-Guillain-Barré syndrome: a clinicopathologic report of fifty fatal cases and a critique of the literature. Medicine 1949;28:59-141.
4. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine 1969;48:173-215.
5. Prineas JW. Acute idiopathic polyneuritis: an electron microscope study. Lab Invest 1972;26:133-147.
6. Prineas JW. Pathology of the Guillain-Barré syndrome. Ann Neurol 1981;9:6-19.
7. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
8. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342.
9. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-595.
10. Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644.
11. Hafer-Macko CE, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:625-635.
12. Kuwabara S, Yuki N, Koga M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 1998;44: 202-208.
13. Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816.
14. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome: Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol 1998;44: 780-788.
15. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996;39: 17-28.
16. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol 1996;25:33-51.
17. Brechenmacher C, Vital C, Deminiere C, et al. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin Neuropathol 1987;6:19-24.
18. Hughes R, Atkinson P, Coates P, et al. Sural nerve biopsies in Guillain-Barré syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome. Muscle Nerve 1992;15:568-575.
19. Nyland H, Matre R, Mork S. Immunological characterization of sural nerve biopsies from patients with Guillain-Barré syndrome. Ann Neurol 1981;9:80-86.
20. Cros D, Triggs WJ. There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome. Muscle Nerve 1994;17:675-657.
21. Massaro ME, Rodriguez EC, Pociecha J, et al. Nerve biopsy in children with severe Guillain-Barré syndrome and inexcitable motor nerves. Neurology 1998;51:394-398.
22. Berciano J, Coria F, Monton F, et al. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination. Muscle Nerve 1993;16:744-751.
23. Feasby TE, Hahn AF, Brown WF, et al. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;116:185-192.
24. Ho TW, Willison HJ, Nachamkin I, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol 1999;45:168-173.
25. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27: S21-S24.
26. Buchthal F, Rosenfalck A, Behse F. Sensory potentials of normal and diseased nerves. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1975:442-464.
27. Bohlega SA, Stigsby B, Haider A, et al. Guillain-Barré syndrome with severe demyelination mimicking axonopathy. Muscle Nerve 1997;20:514-516.
28. Ho TW, Hsieh ST, Nachamkin I, et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 1997;48:717-724.
29. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126.
30. Feasby TE, Gilbert JJ, Brown WF, et al. Acute "axonal" Guillain-Barré polyneuropathy [Letter]. Neurology 1987;37: 357.
31. Feasby TE. Axonal Guillain-Barré syndrome. Muscle Nerve 1994;17:678-679.
32. Hall SM, Hughes RA, Atkinson PF, et al. Motor nerve biopsy in severe Guillain-Barré syndrome. Ann Neurol 1992;31:441-444.
33. Triggs WJ, Cros D, Gominak SC, et al. Motor nerve inexcitability in Guillain-Barré syndrome: the spectrum of distal conduction block and axonal degeneration. Brain 1992;115:1291-1302.
34. Menkes DL, Hood DC. Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases [Letter, comment]. Brain 1996;119:676-677.
35. Griffin JW, Cornblath DR, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathologic changes in clinically defined cases [Reply]. Brain 1996;119: 677-680.
36. Brechenmacher C, Vital C, Laurentjoye L, et al. Ultrastructural study of peripheral nerve in Guillain-Barré syndrome presence of mononuclear cells in axons. Acta Neuropathol Suppl (Berl) 1981;7:249-251.
37. Yuki N, Yoshino H, Sato S, et al. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902.
38. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144.
39. Rees JH, Soudain SE, Gregson NA, et al. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379.
40. Aspinall GO, Fujimoto S, McDonald AG, et al. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immunol 1994;62:2122-2125.
41. Yuki N, Taki T, Takahashi M, et al. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope. Infect Immunol 1994;62:2101-2103.
42. Sheikh KA, Nachamkin I, Ho TW, et al. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology 1998;51:371-378.